...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: plenty of scenarios being put out there...

"Hi KayakerBC. Those words were from Masila's notes...I think she was just using the 100 billion in Royalty STREAM divided by 100 million. I meant to put quotation marks in for her notes but hit the submit button too fast. PVLee "

A 100 billion in royalties for Zenith means RVX would have to have generated about $850 billion in net revenues.

Share
New Message
Please login to post a reply